The most sensitive quantification of a DNA template relies on competitive PCR (9, 10) . This assay is based on competitive co-amplification of a specific target template sequence together with known amounts of a standard in the same test tube. The standard and the template being amplified using the same primers have to exhibit identical sequence at both ends. Moreover, to allow for a reliable quantification, both standard and template have to be PCR amplified with the same efficiency (10, 11) .
There are two kinds of standard used for such quantifications. One corresponds to the target DNA template modified by deletion or insertion of a few bases (homologous standard). This type of standard is used to minimize differences in amplification efficiencies. However, when using it, the denaturation/annealing process leads to the formation of both homoduplex and heteroduplex DNA products that the non -denaturating electrophoresis conditions, commonly used to separate template and standard products, are unable to separate, which promotes a decreased sensitivity and inaccurate measurements (2,7). To overcome this difficulty, denaturating gel electrophoresis can be used, but the use of fluorescent markers is necessary for the quantification of PCR products. Alternatively, one can use an electrophoresis gel (e.g., acrylamide or MDE) that allows a separation of homoduplex and heteroduplex products. A third possibility is the use of a mutant competitor constructed by conversion of one enzyme restriction site to another (8) . However, the use of these methods is costly and time consuming. Another way to overcome heteroduplex formation is to use a nonhomologous DNA sequence as a standard. The risk is that amplification efficiency would not be the same for the standard and the template.
The present work illustrates the fact that one can measure cDNA levels with accuracy using a nonhomologous standard if one applies a correction factor that takes into account the difference in amplification efficiency between standard and template. We have successfully applied this methodology to the quantification of aromatase encoding cDNA present in rabbit granulosa cells.
We recently showed that in this species there are two kinds of aromatase encoding cDNAs of 2.9 and 1.5 kb, respectively, that only differ at their 3 ′ ends ( Figure 1) . We have already shown using Northern blot analysis, that the two cDNAs are present in a similar range (5) . To evaluate the amount of these cDNAs, we quantified the 2.9 and 1.5 kb aromatase cDNAs together ( TaromcDNA) and, separately, the 2.9 Kb cDNA alone ( AaromcDNA) (4, 5) .
Granulosa cells were obtained from preovulatory follicles as described previously (1). 3 ×10 5 cells/well were plated in 0.5 mL MEM supplemented with 5% fetal calf serum (FCS) in 48 well tissue culture plates (Nalge Nunc International, Polylabo, Strasbourg, France). Cells were incubated for 24 h, washed and incubated again in 0.5 mL MEM supplemented with 2.5% FCS with or without 2.5 ng/mL folliclestimulating hormone (FSH) for 24 h. At the end of incubation, the medium was removed and RNA was extracted according to Chomczynski and Sacchi (3). Reverse transcription was performed using all of the RNA extracted from each well, 0. 
For the creation of standards ( Ta std for the quantification of TaromcDNA and Aa stdfor the quantification of AaromcDNA), we used as a nonhomologous sequence a region of the pBR -322 plasmid (9) corresponding to 3750-4002 bp for the Ta std and 106-365 bp for the Aa std . PCR was performed as described previously for the TaromcDNA amplification (except for the annealing step at 66°C) using 5 ng of pBR322 plasmid and 50 pmol of primer (forward 5 ′ -TGAGAAACGT -GGCGACCTGACTAAGTTGGCCG-CAGTGTTATCACTCATGGT-3 ′ ,re -
When studying the linearity of dilution curves in the quantification of Tarom and AaromcDNAs from various aliquots of a total RNA solution, we observed that linearity was obtained for the AaromcDNA but not for the Tarom cDNA (data not shown), suggesting that there was a difference in amplification efficiency for Ta stdand template that varied with the amount of template to be measured. To compare amplification efficiencies for standards and templates, we used a 0.22 micropure separator (Amicon, Grace SA, Epernom, France) to purify the PCR products obtained from amplification of the Aarom and TaromcDNA templates, and quantified them by spectrophotometry at 260 nm. Then, a mixture containing equal amounts of standard and PCR products was diluted (in the range useful in the context of our study) and amplified using the same conditions as described for amplification of cDNA, electrophoresed on a 3% agarose gel at 12 V/cm for 1 h and stained with ethidium bromide. The intensity of staining was measured by densitometry using Bioprofil (Vilberlourmat, Marne la Vallée, France). Figure 2 illustrates variations of the ratio: amount of PCR product/amount of standard as a function of the amount of DNA to be amplified. For the Aarom cDNA, we observed that the ratio was close to 1 regardless of the amount of DNA amplified, which indicates that amplification efficiency was the same for template and standard. For the TaromcDNA, however, the ratio was far from being equal to 1 and varied significantly with the amount of DNA. To take into account the differences in amplification efficiency between standard and template, we applied a correction factor F = 1/ [0.42 + 0.057 log (Xmes)] where Xmes is the amount of template measured (calculated from the regression line observed in Figure 2 TaromcDNA, we calculated a corrected amount Xcorr (Xcorr = F . Xmes).
To test the validity of this correction factor, we compared the results of quantifications performed with or without using a correction for a serial dilution from a known amount of TaromPCR product (Table 1) . Our results indicate that the use of the correction factor improves considerably the reliability of measurements. The linearity of the dilution curve when quantifying Tarom cDNA from various aliquots of total RNA was also obtained after adjustment of the results previously obtained (data not shown). The variation coefficient for reproducibility from experiment to experiment was 20% ( n =10).
We also applied the correction factor when evaluating variations under the influence of added FSH on aromatase mRNA levels in cultured rabbit granulosa cells. The results obtained (expressed as cDNA attomols/3 ×10 5 cells) were (for Aarom) 0.17 ± 0.13 for the unstimulated control cells and 5 ± 1.3 for the FSH-stimulated cells. Stimulation by FSH resulted in an approximately 30-fold increase in Aarom, consistent with previous findings in other species (6) . For Tarom, the values obtained without correction were 0.13 ± 0.11 for control cells and 6.8 ± 2.5 for FSH-treated cells. When using a correction factor, the results became 0.3 ± 0.23 for controls and 13 ± 4.5 for FSHtreated cells. We observed, based on the results obtained without correction, that the Aarom trancript seems to be the only or the main aromatase transcript (representing 100% of the total transcripts for control cells and 70% for FSH-treated cells). Based on the corrected values, it accounts only for half of all transcripts (on the order of 60% for control and 40% for FSH-treated cells). This difference could be important to take into account when investigating a physiological role for the 1.5 kb transcript.
In this report, we have shown that one can use a nonhomologous standard and still obtain an accurate quantification of cDNA even when there is a difference between the amplification efficiencies of the standard and the template to be measured. When using this type of standard, heterodupex formation is avoided and non-denaturing electrophoresis conditions are not required. We have also shown that differences between amplification efficiencies of the standard and the template may vary with the amount of cDNA to be measured. For a precise quantification of cDNA or even for a simple comparison of the relative amounts of cDNA from various samples, it is necessary to evaluate beforehand the relative amplification efficiency of standard and template in a range adequate to the context of the study. This would apply not only to cDNA measurements using a nonhomologous standard but also, eventually, to those using a homologous one.
